Surgery Doctors in Natrona Heights, PA Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Michelle L Zuba, DO Surgery Medicare: Medicare Enrolled Practice Location: 1629 Union Ave, Suite 4, Natrona Heights, PA 15065 Phone: 724-226-7415    Fax: 724-226-7109

Fernando D Hayetian, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1629 Union Ave Ste 4, Natrona Heights, PA 15065 Phone: 724-671-1161    Fax: 724-671-1170

Yelena Lyubarsky, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1629 Union Ave Ste 4, Natrona Heights, PA 15065 Phone: 724-671-1161    Fax: 724-671-1170

John T Hower, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1629 Union Ave Ste 4, Natrona Heights, PA 15065 Phone: 724-671-1161    Fax: 724-671-1170

News Archive

Dartmouth study uncovers three novel genetic biomarkers for lung cancer

Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, PhD, has conducted a study to display that gene-smoking interactions play important roles in the etiology of lung cancer.

FDA issues two final orders to strengthen requirements for transvaginal surgical mesh safety

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) transvaginally, or through the vagina.

Phase 3 study on novel oral direct thrombin inhibitor

Boehringer Ingelheim has announced that the September 15 issue of The Lancet will publish results from the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing total hip replacement surgery.

Provectus to begin clinical trials of new cancer treatment, PV-10

Provectus Pharmaceuticals announced today that it has obtained final clearance to begin the first Phase 1 clinical trial of PV-10, the Company's lead cancer treatment.

Financial Times' opinions on World TB Day

"Governments and their international partners must recognise that health is an investment. The only successful exit strategy in the struggle against the TB, HIV and TB/HIV pandemics is to include them as part of broader development and poverty reduction strategies, and to strengthen health systems to respond more effectively to the needs of the most vulnerable populations.

Read more Medical News

› Verified 4 days ago